Q4 2024 · 13F-HR
BML Capital Management, LLCholdings as filed
Filed 2025-02-07 · accession 0001754960-25-000111
$161.0M
Reported value
25
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $35.3M | 22.0% | 14,250,000 | Common | NONE |
| 46436E718 | SGOV | ISHARES TR | $26.1M | 16.2% | 260,000 | Common | NONE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $25.5M | 15.8% | 7,608,312 | Common | NONE |
| 00773U207 | AVU0 | ADVERUM BIOTECHNOLOGIES INC | $10.6M | 6.58% | 2,268,064 | Common | NONE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $7.9M | 4.93% | 5,749,432 | Common | NONE |
| 45783C200 | TIL | INSTIL BIO INC | $7.6M | 4.74% | 400,000 | Common | NONE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $7.6M | 4.69% | 4,221,546 | Common | NONE |
| 00032Q104 | WHWK | AADI BIOSCIENCE INC | $6.6M | 4.12% | 2,100,000 | Common | NONE |
| 68403P203 | ORMP | ORAMED PHARMACEUTICALS INC | $6.4M | 3.97% | 2,643,907 | Common | NONE |
| 45175G108 | — | IKENA ONCOLOGY INC | $5.9M | 3.65% | 3,585,866 | Common | NONE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $5.2M | 3.25% | 3,466,684 | Common | NONE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $4.7M | 2.90% | 4,100,002 | Common | NONE |
| 207523101 | — | CONNECT BIOPHARMA HLDGS LTD | $2.9M | 1.79% | 2,093,232 | Common | NONE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $2.7M | 1.67% | 1,136,091 | Common | NONE |
| 04746L104 | — | ATHIRA PHARMA INC | $1.6M | 1.01% | 2,775,885 | Common | NONE |
| 046484309 | ASTC | ASTROTECH CORP | $1.5M | 0.92% | 220,410 | Common | NONE |
| 128058302 | LSTA | LISATA THERAPEUTICS INC | $848,314 | 0.53% | 284,669 | Common | NONE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $505,560 | 0.31% | 42,130 | Common | NONE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $442,500 | 0.27% | 150,000 | Common | NONE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $327,049 | 0.20% | 48,668 | Common | NONE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $267,654 | 0.17% | 9,271 | Common | NONE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $210,896 | 0.13% | 273,536 | Common | NONE |
| 92511W108 | — | VERRICA PHARMACEUTICALS INC | $122,256 | 0.08% | 174,651 | Common | NONE |
| 019818103 | — | ALLOVIR INC | $77,383 | 0.05% | 184,246 | Common | NONE |
| 43157M102 | — | HILLEVAX INC | $42,973 | 0.03% | 20,760 | Common | NONE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.